treatment, and outcomes. TAAAD was defined as any nontraumatic dissection of the aorta proximal to the left subclavian artery presenting within 14 days of symptom onset. Stroke was defined in the database lexicon as a cerebrovascular accident representing a loss of neurological function (loss or slurring of speech, altered state of consciousness) caused by an ischemic event, confirmed by computed tomography or MRI. This definition of stroke was formulated to be conservative, considering that not all patients had routine neurological consults postdissection. Therefore, we have probably somewhat underestimated the incidence of less obvious neurological injuries. Other definitions were similar to those in previous publications. [6] [7] [8] 
Statistical Analysis
Data are shown as frequencies and percentages, mean±SD, or medians with first and third quartiles. Univariate comparisons between patients with and without stroke were performed using the χ 2 test for categorical data and Student t test for continuous variables with normal data distributions. Nonparametric test of medians was used for data with skewed distributions. In all cases, missing data were not defaulted to negative, and denominators reflect cases for which information was reported. Binary logistic regression analysis was performed to determine the independent correlates of presenting stroke and to assess the independent association of presenting stroke with in-hospital mortality. Cox proportional hazard models were used to identify the independent association of stroke with long-term mortality among patients discharged alive at hospitalization. Odds ratios and hazard ratios with their corresponding 95% confidence intervals were generated to provide an estimate of these associations. All P values were 2-sided, with values <0.05 considered statistically significant. Analyses were performed using SPSS 20.0 statistical analysis software (IBM Corporation).
Results

Incidence, Demographics, History, and Clinical Symptoms and Signs
Among 2202 patients with TAAAD enrolled in IRAD, 132 (6.0%) had stroke at presentation (Table 1) . These patients were older, with only 1 stroke patient <40 years of age. A history of hypertension was 1.2× more common in patients with stroke, and atherosclerosis was ≈1.4-fold higher in the stroke cohort compared with nonstroke patients. Presentation with chest or back pain was less frequent, whereas presentation with syncope was 3-fold higher among TAAAD patients with stroke. Shock and pulse deficit were 2-fold higher, and the combination of shock, hypotension, and cardiac tamponade was 1.4× higher among patients with stroke. Other demographics, clinical features, and presenting symptoms were similar between groups ( Table 2 ).
Diagnostic Imaging and Use of Medications
The use of diagnostic imaging techniques was similar in patients with and without stroke. Chest radiograph, ECG, and imaging study findings were also similar between cohorts, with the exception of more arch involvement in patients with stroke (Table 3) .
Patients with stroke had lower in-hospital β-blocker use; otherwise, use of evidence-based medical therapies at presentation and discharge was similar between groups ( Table 4 ). Patients with stroke were twice as likely to undergo nonoperative management compared with those without stroke.
Complications and In-Hospital Mortality
In-hospital complications, such as hypotension and coma, were significantly higher in patients with stroke, who also demonstrated a trend toward greater incidence of malperfusion syndrome ( Table 5 ). Although almost all other complications were higher in patients with stroke, these differences did not reach statistical significance. Median length of stay was 4.8 days longer in patients with stroke (17.8 days with stroke, Q1-Q3: 12.1-31.1 days; 13.0 days without, Q1-Q3: 8.6-21.0 days; P<0.001). Finally, overall mortality was 1.8-fold higher in patients with stroke (adjusted odds ratios, 1.62; 95% confidence interval, 0.99-2.65; P=0.055). Mortality was higher in patients with stroke compared with nonstroke patients with 
Independent Clinical Correlates of Presenting Stroke and In-Hospital Mortality
Arch vessel involvement on imaging was the greatest predictor of stroke (Table 6 ). In addition, syncope, abdominal pain, presenting pulse deficit, abnormal chest radiograph without accompanying pain, and history of hypertension had significant independent adjusted correlations with stroke in our cohort.
In TAAAD patients presenting with stroke, surgical management had strong independent adjusted associations with improved survival (Table 7) . Variables with independent adjusted associations with decreased survival included coma, pleural effusion, pulse deficit on presentation, and mesenteric ischemia.
Discussion
Our study, the largest to date, suggests that stroke at hospital admission is observed in 6% of patients with TAAAD. These patients were older, more often had hypertension and atherosclerosis, and presented more frequently with symptoms such as syncope rather than the more classic presentation of chest or back pain. Patients with stroke were also likely to have signs of hypotension, shock, and pulse deficit. Except aortic arch involvement, imaging study findings were similar between groups. Medical therapies in hospital and at discharge were similar in the 2 groups, with the lower use of in-hospital β-blocker among stroke patients likely a reflection of the more frequent hypotension and shock in these patients. Patients with stroke were more likely to be managed medically and had greater length of stay. In-hospital mortality was higher in patients with stroke compared with nonstroke patients, regardless of the management strategy; however, postdischarge mortality did not differ between groups.
Few studies have focused on stroke in patients with TAAAD, most of which are single-center case reports 9-15 evaluating a small number of patients with few stroke events. [2] [3] [4] [5] 16 These studies described a stroke incidence between 3% and 32% in 24 to 174 patients with TAAAD. Similar to our findings, some studies reported more frequent painless presentation, syncope, and hypotension in patients with stroke. Furthermore, most studies suggested a higher mortality for patients with stroke compared with those without it. Most of these reports focused primarily on patients undergoing surgery, and many did not characterize the factors associated with risk of presenting stroke and mortality in those with stroke. 
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Our findings may have several implications for patients with TAAAD and presenting stroke. In addition to chest or back pain preceding the stroke, this and other studies suggest that a high index of suspicion should also be made for TAAAD in stroke patients who present with syncope hypotension, pulse deficit, and a murmur of aortic regurgitation. In patients with these symptoms, early imaging would enable diagnosis of TAAAD if present and help prevent inadvertent use of fibrinolytic therapy that could lead to fatal outcomes in this cohort. 10, 12, [17] [18] [19] Urgent surgical repair is required for TAAAD because conservative management is associated with a high incidence of early mortality. 6 However, some studies have suggested that immediate surgical repair of TAAAD in the presence of stroke has a prohibitive risk associated with hemorrhagic worsening of an ischemic infarction after reperfusion subsequent to cardiopulmonary bypass and full anticoagulation. 20, 21 Others have suggested that delaying repair until cerebral injury stabilizes may minimize these concerns, albeit exposing patients to an early hazard of death from rupture. 22 However, Fann et al 3 reported no worsening of cerebral symptoms in 7 surgically treated patients with TAAAD. Several small studies have since corroborated the feasibility and safety of early surgical repair in TAAAD patients with stroke. 9, 13, 16, 23, 24 In fact, 1 study suggested no benefit of surgery beyond 12 hours when cerebral damage is almost complete. 16 Deeb et al 25 have suggested good results with a hybrid approach involving fenestrations for immediate percutaneous reperfusion followed by surgery after the brain tissue has healed. Although our data suggest that surgically treated TAAAD patients with stroke had higher mortality than those without stroke, surgical patients had much lower mortality than patients treated medically, regardless of whether they presented with stroke. Furthermore, adjusted survival estimates for patients with TAAAD suggested that among surgically treated patients with TAAAD discharged alive at index hospitalization, ≈4 of 5 patients survived at 5-year follow-up, whereas long-term outcomes were dismal among stroke patients treated medically (100% mortality). Our results and those of previous studies suggest, compared with medical therapy, that definitive early repair in TAAAD patients presenting with stroke is safe and likely associated with lower short-and long-term mortality. Further studies are warranted in TAAAD patients presenting with stroke to determine which stroke patients will benefit more from surgery and whether or not stroke severity impacts outcomes. In addition, analyses should be performed to determine the optimal timing of surgery (early versus late) and to compare outcomes between surgical strategies used in this cohort.
Limitations
Patients in this study had TAAAD and were admitted to centers specializing in aortic disease. Thus, our results may not be applicable to those with chronic TAAAD, type B AAD, or those treated at smaller centers. IRAD data are collected retrospectively and prospectively through voluntary site participation and are subject to incomplete information, particularly with regard to long-term outcomes. As such, some strokes may have not been adequately captured in the registry. Furthermore, because IRAD is composed of tertiary care centers, patients with TAAAD and stroke who died at primary care centers or who were unable to be transferred secondary to their acute illness were not included. Treatment strategies were not protocol driven and were determined by the treating physicians. Thus, inference regarding the effectiveness of various strategies on outcomes in these patient cohorts should be made with caution. Imaging results were based on interpretation at the IRAD center and were not independently adjudicated. We are also unable to provide any details on stroke size, extent of debilitation after stroke, or improvement or resolution of neurological symptoms.
Conclusions
Stroke occurred in >1 of 20 patients with TAAAD and was associated with increased morbidity and in-hospital mortality, but not higher long-term mortality among survivors. Our data suggest that aggressive early intervention with rapid establishment of cerebral flow and surgical repair of dissection have significant potential for reducing morbidity and improving mortality.
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